RxDoctor Payments Data

Boonpon Thongteum, NP

Nurse Practitioner · Winston-Salem, NCNPI 1255392536

Payments from drug & device makers

$2,958in general payments, 2019–2025

Across 177 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • E.r. Squibb & Sons, L.L.C.$632
  • Abbott$151
  • Vital Connect, Inc$138
  • Cvrx, Inc.$127
  • Boston Scientific$114
  • plus $312 from 7 others

What the payments were for

  • Travel & lodging$82328%
  • Food & beverage$2,13572%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,958 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$63,415
Medicare patients
605
Services billed
1,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban390$339,720
XareltoRivaroxaban60$72,470
EntrestoSacubitril/Valsartan38$53,107
MultaqDronedarone Hcl26$23,185
FarxigaDapagliflozin Propanediol16$14,767
JardianceEmpagliflozin16$10,532
Metoprolol Succinate297$3,630
Diltiazem 24hr Er (Cd)Diltiazem Hcl83$2,704
Mexiletine Hcl16$2,197
Amiodarone Hcl153$1,769
Ranolazine ErRanolazine25$1,744
Digoxin77$1,691
Carvedilol170$1,419
Flecainide Acetate33$983
Losartan Potassium54$692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$43$339,720390 claims
NovartisEntresto$61$53,10738 claims
Boehringer IngelheimJardiance$36$10,53216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Winston-Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →